XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in-Capital
Accumulated Other Comprehensive Gain/(Loss)
Treasury Stock
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 6,084 $ 7,297,306 $ (26,004) $ (96,261) $ (3,120,911) $ 4,060,214
Balance (in shares) at Dec. 31, 2022 608,421,785     18,076,127    
Increase (Decrease) in Stockholders' Equity            
Net loss         (206,561) (206,561)
Other comprehensive loss     6,970     6,970
Stock-based compensation $ 2 43,300       43,302
Stock-based compensation (in shares) 228,954          
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards $ 6 668       674
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards (in shares) 620,250          
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards       $ (2,590)   (2,590)
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards (in shares)       169,787    
Exercise of warrants $ 28 (28)        
Exercise of warrants (in shares) 2,680,637          
Provision for common stock warrants   19,641       19,641
Balance at Mar. 31, 2023 $ 6,120 7,360,887 (19,034) $ (98,851) (3,327,472) 3,921,650
Balance (in shares) at Mar. 31, 2023 611,951,626     18,245,914    
Balance at Dec. 31, 2023 $ 6,254 7,494,685 (6,802) $ (106,268) (4,489,744) $ 2,898,125
Balance (in shares) at Dec. 31, 2023 625,305,025     19,169,366   625,305,025
Increase (Decrease) in Stockholders' Equity            
Net loss         (295,776) $ (295,776)
Other comprehensive loss     (2,276)     (2,276)
Stock-based compensation $ 9 13,695       13,704
Stock-based compensation (in shares) 923,027          
Public offerings, common stock, net of issuance costs $ 796 304,550       305,346
Public offerings, common stock, net of issuance costs (in shares) 79,553,175          
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards $ (2) 43       41
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards (in shares) (176,678)          
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards       $ (278)   (278)
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards (in shares)       72,849    
Provision for common stock warrants   10,236       10,236
Balance at Mar. 31, 2024 $ 7,057 $ 7,823,209 $ (9,078) $ (106,546) $ (4,785,520) $ 2,929,122
Balance (in shares) at Mar. 31, 2024 705,604,549     19,242,215   705,604,549